Short description
Mitokinin is operates in the healthcare industry focusing on biotechnology business.
Description
Mitokinin is operates in the healthcare industry focusing on biotechnology business. It launches medicinal chemistry effort to generate kinetin analogs optimized for activating PINK1. It plans to develop the analog or optimized variants to treat Parkinson's disease.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
San Francisco, California, United States, North America
Founded on
January 1, 2017
Exited on
March 10, 2021
Non-profit?
No
Acquired?
No
Employees count
11-50
Revenue range
$56378 - 90123
Sign in for full access
Investors
Uh Ohhhh, Noway Youcantaccess
Sign in for full access
Founders
Daniel De Roulet, Kevan Shokat, Nicholas Hertz